Why the study?
Long-term toxicities affect many breast cancer survivors, and while guidelines exist for isolated side effects, an inclusive clinical-oriented approach addressing prevention and therapeutic strategies is needed.
Provides a clinical-oriented approach for the prevention and therapeutic management of long-term side effects of chemotherapy in early breast cancer survivors.
May inform survivorship care planning in breast cancer; leaves open prospective validation of recommendations.
Long-term toxicities may affect a majority of breast cancer survivors, significantly interfering with their quality of life. Although there are guidelines for the management of isolated side effects, such as peripheral neuropathy, we aim to provide a more inclusive clinical-oriented approach, focusing on both prevention and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Nardo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: